Company Filing History:

10 out of 1,451

Sanofi

Years Active: 1992-2006

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7119086 - Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use (2006-10-10),

2. 5849780 - 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their (1998-12-15),

3. 5773612 - Indol-2-one derivatives (1998-06-30),

4. 5728723 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation (1998-03-17),

5. 5726322 - 1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation (1998-03-10),

6. 5686624 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation (1997-11-11),

7. 5663431 - 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation (1997-09-02),

8. 5661169 - 1-benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their (1997-08-26),

9. 5594023 - 1,3-dihydroindol-2-one derivatives substituted in the 3-position by a (1997-01-14),

10. 5585394 - 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives (1996-12-17),

11. 5151442 - Chroman derivative active on the central nervous system, their method of (1992-09-29),

Introduction

Alain Di Malta is a distinguished inventor based in Saint Clement de Riviere, France. With a remarkable portfolio of 11 patents, his contributions to pharmaceutical chemistry focus primarily on compounds that target specific receptors, with therapeutic applications that hold promise for various medical treatments.

Latest Patents

Among Alain Di Malta's latest patents are innovative derivatives, such as the Phenylsulfonyl-1,3-dihydro-2h-indole-2-one. This invention details compounds with a specific formula and explores their therapeutic use. These compounds demonstrate affinity and selectivity toward arginine-vasopressin V-receptors and oxytocin receptors, with implications for medicinal products.

Another notable patent is for 1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives. This invention also targets the aforementioned receptors and discusses their preparation as well as potential applications in pharmaceutical compositions.

Career Highlights

Alain Di Malta has an impressive career, including significant roles at reputable companies such as Sanofi and Sanofi-Aventis. His work at these organizations has enabled him to push the boundaries of pharmaceutical research and development, resulting in valuable intellectual properties.

Collaborations

Throughout his career, Alain has collaborated with esteemed colleagues such as Richard Roux and Georges Garcia. These partnerships have not only enriched his innovative endeavors but also contributed to the development of advanced therapeutic compounds.

Conclusion

Alain Di Malta's extensive contributions to the field of pharmaceutical chemistry exemplify his expertise as an inventor. His innovative patents point toward a future where targeted therapies can provide new treatment avenues for patients. As he continues to collaborate and innovate, the impact of his work will undoubtedly reverberate throughout the medical community.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.